This new series profiles the members of edie's 30 Under 30 - a nomination-based community of 30 hugely talented young ...

The GGY figure leads the update of operator datasets published by the UK Gambling Commission (UKGC), tracking changes in ...

The FDA has approved a companion diagnostic to determine if patients with HR-positive, HER2-ultralow metastatic breast cancer are eligible for T-DXd treatment.

In the Phase II MAIA lung cancer trial, THIO improved patients’ overall survival when taken in combination with Libtayo.

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

The exploited vulnerability, tracked as CVE-2024-53104 (CVSS score of 7.8), is a high-severity out-of-bounds write bug that ...

While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...

Pfizer (PFE) announced positive topline results from the progression-free survival – PFS – analysis of the Phase 3 BREAKWATER study of Braftovi ...

Economic Survey highlights infrastructure progress, emphasizing need for private sector participation and sustainable ...

Colin Wiel, the founder of Qurrent, is driving innovation with their AI Operating System, empowering businesses to achieve ...

Quoting the Chinese proverb, "May we live in interesting times!" the Survey noted that it is especially relevant in today's ...